Displaying drugs 2351 - 2375 of 2773 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Rolitetracycline | 527.5662 C27H33N3O8 |  | A broad-spectrum tetracycline antibiotic used in cases needing high concentrations or when oral administration is impractical. | Tetracyclines |
| Gliquidone | 527.632 C27H33N3O6S |  | A sulfonylurea drug used in the management of diabetes mellitus type 2. | Sulfonylureas |
| Dutasteride | 528.5297 C27H30F6N2O2 |  | An antiandrogenic compound that is used for the treatment of symptomatic benign prostatic hyperplasia (BPH) in adult males by inhibiting 5-alpha reductase. | Adrenergic alpha-Antagonists |
| Lumefantrine | 528.94 C30H32Cl3NO |  | An antimalarial agent used in combination with artemether for the treatment of acute uncomplicated malaria caused by Plasmodium falciparum. | Antiprotozoals |
| Sofosbuvir | 529.458 C22H29FN3O9P |  | A direct-acting antiviral agent used to treat specific hepatitis C virus (HCV) infections in combination with other antiviral agents. | Antivirals for treatment of HCV infections |
| Nilotinib | 529.5158 C28H22F3N7O |  | A kinase inhibitor used for the chronic phase treatment of Chronic Myeloid Leukemia (CML) that is Philadelphia chromosome positive and for the treatment of CML that is resistant to therapy containing imatinib. | Protein Kinase Inhibitors |
| Rocuronium | 529.7742 C32H53N2O4 |  | A vecuronium analog used to facilitate tracheal intubation and to relax skeletal muscles during surgery. | Agents producing tachycardia |
| Bortezomib D-mannitol | 530.39 C25H35BN4O8 |  | Not Annotated | Proteasome Inhibitors |
| Bosutinib | 530.446 C26H29Cl2N5O3 |  | An antineoplastic agent used for the treatment of chronic, accelerated, or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) in adults with inadequate clinical response to other treatments. | Bcr-Abl Tyrosine Kinase Inhibitors / Protein Kinase Inhibitors |
| Glycerol phenylbutyrate | 530.6512 C33H38O6 |  | A nitrogen-binding agent used to manage patients with urea cycle disorders who cannot be sufficiently managed amino acid supplementation and/or dietary restrictions. | Various Alimentary Tract and Metabolism Products |
| alpha-Tocopherol succinate | 530.79 C33H54O5 |  | A form of vitamin E used to treat and prevent vitamin deficiencies. | Antioxidants / Tocopherols / Vitamins |
| Cobimetinib | 531.318 C21H21F3IN3O2 |  | An antineoplastic agent and selective inhibitor of the mitogen-activated extracellular kinase (MEK) pathway used to treat unresectable or metastatic melanoma. | Mitogen-activated protein kinase (MEK) inhibitors / Protein Kinase Inhibitors |
| Ketoconazole | 531.431 C26H28Cl2N4O4 |  | A broad spectrum antifungal used to treat seborrheic dermatitis and fungal skin infections. | Anticorticosteroids / Imidazole and Triazole Derivatives / Imidazole Derivatives |
| Levoketoconazole | 531.431 C26H28Cl2N4O4 |  | One of two enantiomeric forms of racemic ketoconazole that strongly inhibits multiple steroidogenic enzymes and is used for the symptomatic treatment of endogenous Cushing's syndrome. | Anticorticosteroids |
| Terconazole | 532.47 C26H31Cl2N5O3 |  | An antifungal drug used in the treatment of vulvovaginal candidiasis. | Triazole Derivatives |
| Ponatinib | 532.5595 C29H27F3N6O |  | A kinase inhibitor used to treat patients with various types of chronic myeloid leukemia (CML). | Bcr-Abl Tyrosine Kinase Inhibitors / Protein Kinase Inhibitors |
| Pralsetinib | 533.612 C27H32FN9O2 |  | A RET receptor tyrosine kinase inhibitor for the treatment of metastatic RET-driven non-small cell lung cancer. | Antineoplastic Agents / Kinase Inhibitor |
| Aprepitant | 534.4267 C23H21F7N4O3 |  | A substance P/neurokinin 1 receptor antagonist used to treat nausea and vomiting caused by chemotherapy and surgery. | Antiemetics / Morpholines / Neurokinin-1 Receptor Antagonists / Substance P/Neurokinin-1 Receptor Antagonist |
| Delamanid | 534.492 C25H25F3N4O6 |  | An antibiotic used to treat multidrug resistant tuberculosis. | Antiinfectives for Systemic Use / Antimycobacterials / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates / Drugs for Treatment of Tuberculosis / Imidazoles / Moderate Risk QTc-Prolonging Agents / Nitro Compounds / QTc Prolonging Agents |
| Rimegepant | 534.568 C28H28F2N6O3 |  | An oral CGRP receptor antagonist used for the acute treatment of migraines with or without aura in adults. | Calcitonin Gene-Related Peptide (CGRP) Antagonists |
| Ceftobiprole | 534.57 C20H22N8O6S2 |  | A cephalosporin antibiotic used to treat both community and hospital-acquired pneumonia caused by susceptible bacteria. | Anti-Bacterial Agents |
| Piperaquine | 535.52 C29H32Cl2N6 |  | For the treatment of uncomplicated Plasmodium falciparum infection in adults, children, and infants aged 6 months and up weighing over 5 kg [FDA Label]. Used in combination with DB11638. | Anti-Infective Agents / Antimalarials / Antiparasitic Agents / Antiparasitic Products, Insecticides and Repellents / Antiprotozoals / Cytochrome P-450 CYP2B6 Inhibitors / Cytochrome P-450 CYP2B6 Inhibitors (weak) / Cytochrome P-450 CYP2C19 Inhibitors / Cytochrome P-450 CYP2C19 inhibitors (strength unknown) / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP2E1 Inducers / Cytochrome P-450 CYP2E1 Inducers (strength unknown) / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (weak) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Heterocyclic Compounds, Fused-Ring |
| Lycopene | 536.888 C40H56 |  | An ingredient found in a variety of supplements and vitamins. | Anti-Inflammatory Agents / Anticarcinogenic Agents / Antioxidants / Carotenoids / Radiation-Protective Agents |
| Beta carotene | 536.888 C40H56 |  | A vitamin A precursor found in various nutritional supplements and health products. | Protectives Against UV-Radiation for Systemic Use |
| Ambenonium | 537.565 C28H42Cl2N4O2 |  | A cholinesterase inhibitor that targets both muscarinic and nicotinic receptors indicated for the treatment of myasthenia gravis. | Parasympathomimetics |
Displaying drugs 2351 - 2375 of 2773 in total